These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22946951)

  • 1. Practical and statistical considerations on simultaneous global drug development.
    Li N; Wang W
    J Biopharm Stat; 2012 Sep; 22(5):1074-7. PubMed ID: 22946951
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and sample size considerations for simultaneous global drug development program.
    Huang Q; Chen G; Yuan Z; Lan KK
    J Biopharm Stat; 2012 Sep; 22(5):1060-73. PubMed ID: 22946950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

  • 4. Guest editors' note for the special issue on the statistical considerations for the design and analysis of bridging and multiregional clinical trials.
    Tsong Y; Wang W
    J Biopharm Stat; 2012 Sep; 22(5):875-8. PubMed ID: 22946936
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical Properties of the Design for Simultaneous Global Drug Development Program.
    Liu K; Yuan Z; Chen G; Huang Q; Wenrich J
    J Biopharm Stat; 2015; 25(6):1135-44. PubMed ID: 25321600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of homogeneity of treatment effect in adaptive multicenter clinical trials.
    Chen L; Tamura RN
    J Biopharm Stat; 1998 Mar; 8(1):55-67. PubMed ID: 9547427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional consistency and sample size considerations in a multiregional equivalence trial.
    Wu SC; Xu JF; Zhang XJ; Li ZW; He J
    Pharm Stat; 2020 Nov; 19(6):897-908. PubMed ID: 32716135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Quantitative Method for Weight Selection in SGDDP.
    Huang Q; Chen G; Yuan Z; Zhang Y; Wenrich J
    J Biopharm Stat; 2015; 25(6):1179-89. PubMed ID: 25365548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical reporting of clinical pharmacology research.
    Ring A; Schall R; Loke YK; Day S
    Br J Clin Pharmacol; 2017 Jun; 83(6):1159-1162. PubMed ID: 28321897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on two approaches of testing bridging evidence to a new region.
    Dong X; Guo Y; Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):966-76. PubMed ID: 22946943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiregional clinical trials: Japanese perspective on drug development strategy and sample size for Japanese subjects.
    Ando Y; Uyama Y
    J Biopharm Stat; 2012 Sep; 22(5):977-87. PubMed ID: 22946944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.
    Smith BP; Vincent J
    Clin Pharmacol Ther; 2010 Aug; 88(2):141-4. PubMed ID: 20648027
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of regional treatment effect in a multiregional clinical trial.
    Tsong Y; Chang WJ; Dong X; Tsou HH
    J Biopharm Stat; 2012 Sep; 22(5):1019-36. PubMed ID: 22946947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative approaches to clinical development and trial design.
    Orloff JJ; Stanski D
    Ann Ist Super Sanita; 2011; 47(1):8-13. PubMed ID: 21430331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive Bayesian approach to the design and analysis of bridging studies.
    Gould AL; Jin T; Zhang LX; Wang WW
    J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal allocation of sample sizes to multicenter clinical trials.
    Lai D; Chang KC; Rahbar MH; Moye LA
    J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision rules and associated sample size planning for regional approval utilizing multiregional clinical trials.
    Chen X; Lu N; Nair R; Xu Y; Kang C; Huang Q; Li N; Chen H
    J Biopharm Stat; 2012 Sep; 22(5):1001-18. PubMed ID: 22946946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial: myths around elementary statistical principles.
    Edler L; Kopp-Schneider A
    Onkologie; 2003 Dec; 26(6):551-6. PubMed ID: 14709929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous inference for semiparametric mixed-effects joint models with skew distribution and covariate measurement error for longitudinal competing risks data analysis.
    Lu T
    J Biopharm Stat; 2017; 27(6):1009-1027. PubMed ID: 28272995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.